An observational study in Erectile Dysfunction, sponsored by Bayer. Terminated at 1 site in Taiwan. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-05-19.
Sponsored by Bayer · Observational
In this uncontrolled, non-randomized, prospective, local post-marketed surveillance study, data are obtained on safety and efficacy of LEVITRA® in routine treatment of erectile dysfunction. The general objectives are to evaluate the product safety (primarily by recording adverse events), efficacy and patient acceptance.
682 studies on the registry are indexed under Erectile Dysfunction; 116 are open to participants now.
This study's enrollment of 372 is above the median of 130 across 115 observational studies indexed under Erectile Dysfunction.
Browse Erectile Dysfunction studies →Bayer is the lead sponsor of 1,643 studies on the registry; 57 are open to participants now.
Of its 209 completed or terminated interventional studies of FDA-regulated products, 129 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Primary care clinics
Exclusion Criteria:
Drug: Vardenafil (Levitra, BAY38-9456)
5 mg or 10 mg or 20 mg of Vardenafil, orally when necessary for 2 months
General assessment of patients concerning efficacy and tolerability of vardenafil treatment
Time frame: 2 months
Time to first intercourse after intake of vardenafil
Time frame: 2 months
Percentage of successful second intercourse within 24 hours
Time frame: 2 months
Percentage of participants who are willing to continue treatment
Time frame: 2 months
Number of participants with adverse events
Time frame: 2 months
This study is terminated, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bayer